John Volpone
Vermogen: 1 M $ op 31-05-2026
Vermogen: 1 M $ op 31-05-2026
John Volpone is currently Chief Operating Officer at X4 Pharmaceuticals, Inc. Formerly, Mr. Volpone was Director-Business Development at ZymoGenetics, Inc. and Senior Vice President-Strategic Operations at.
CTI BioPharma Corp.
Education includes an undergraduate degree from the University of Washington and an MBA from Seattle University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 29-10-2025 | 289.881 ( 0,31% ) | 1 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Operationeel Directeur | 16-09-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
| CTI BIOPHARMA CORP. | Human Resources Officer | 01-10-2023 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 5 |
|---|---|
CTI BioPharma Corp.
CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seattle University
Seattle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau